Cargando…

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial

OBJECTIVE: Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved from the cell membrane. Both sRAGE and esRAGE have been proposed as biomarkers of cardiovascular disease (CVD), but prospective da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colhoun, Helen M., Betteridge, D. John, Durrington, Paul, Hitman, Graham, Neil, Andrew, Livingstone, Shona, Charlton-Menys, Valentine, Bao, Weihang, DeMicco, David A., Preston, Gregory M., Deshmukh, Harshal, Tan, Kathryn, Fuller, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161327/ https://www.ncbi.nlm.nih.gov/pubmed/21771973 http://dx.doi.org/10.2337/db11-0291

Ejemplares similares

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2015)

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)
por: Livingstone, Shona J., et al.
Publicado: (2015)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes
por: Selvin, Elizabeth, et al.
Publicado: (2011)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
por: Lopes-Virella, Maria F., et al.
Publicado: (2011)

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2016)

Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
por: McVicar, Carmel M., et al.
Publicado: (2011)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts
por: Guillon, Cécile, et al.
Publicado: (2021)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy
por: Gruden, Gabriella, et al.
Publicado: (2008)

Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018)

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
por: Barzilay, Joshua I., et al.
Publicado: (2014)

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2014)

Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration
por: Dinh, Thanh, et al.
Publicado: (2012)

Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse: A Model of Type 2 Diabetes
por: Pande, Manjusha, et al.
Publicado: (2011)

Role of Transcription Factor Acetylation in Diabetic Kidney Disease
por: Liu, Ruijie, et al.
Publicado: (2014)

Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
por: Clarke, John D., et al.
Publicado: (2015)

Heterogeneous Nuclear Ribonucleoprotein F Suppresses Angiotensinogen Gene Expression and Attenuates Hypertension and Kidney Injury in Diabetic Mice
por: Lo, Chao-Sheng, et al.
Publicado: (2012)

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Polak, Joseph F., et al.
Publicado: (2011)

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes
por: Hur, Junguk, et al.
Publicado: (2015)

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
por: Fadini, Gian Paolo, et al.
Publicado: (2015)

Catalase Overexpression Prevents Nuclear Factor Erythroid 2–Related Factor 2 Stimulation of Renal Angiotensinogen Gene Expression, Hypertension, and Kidney Injury in Diabetic Mice
por: Abdo, Shaaban, et al.
Publicado: (2014)

Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
por: Fan, Ying, et al.
Publicado: (2019)

Alstrom syndrome (OMIM 203800): a case report and literature review
por: Joy, Tisha, et al.
Publicado: (2007)

PPARδ Activation Protects Endothelial Function in Diabetic Mice
por: Tian, Xiao Yu, et al.
Publicado: (2012)

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
por: Miao, Feng, et al.
Publicado: (2014)

BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice
por: Fan, Ying, et al.
Publicado: (2015)

A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions
por: Liu, Chenghao, et al.
Publicado: (2020)

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies
por: Tang, Yaling, et al.
Publicado: (2019)

Bcl-2–Modifying Factor Induces Renal Proximal Tubular Cell Apoptosis in Diabetic Mice
por: Lau, Garnet J., et al.
Publicado: (2012)

Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
por: Mzhavia, Nino, et al.
Publicado: (2008)

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
por: Kawahara, Shuhei, et al.
Publicado: (2008)

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008)

Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats
por: Berti-Mattera, Liliana N., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rf2mj1cm6fr9gvev8hs6d0lthd